Compare PTCT & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | SGHC |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | Guernsey |
| Employees | 991 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.4B |
| IPO Year | 2006 | 2021 |
| Metric | PTCT | SGHC |
|---|---|---|
| Price | $63.29 | $12.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | ★ $80.65 | $17.33 |
| AVG Volume (30 Days) | 918.2K | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 0.90 | N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $16.09 |
| Revenue Next Year | $17.70 | $9.73 |
| P/E Ratio | $69.20 | ★ $20.80 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $58.90 | $8.46 |
| 52 Week High | $90.87 | $15.86 |
| Indicator | PTCT | SGHC |
|---|---|---|
| Relative Strength Index (RSI) | 34.72 | 29.42 |
| Support Level | N/A | $10.16 |
| Resistance Level | $68.93 | $12.24 |
| Average True Range (ATR) | 1.97 | 0.44 |
| MACD | -0.32 | -0.17 |
| Stochastic Oscillator | 22.43 | 22.57 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's four operating segments-Betway, Spin, Jumpman and DGC. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.